Top Markets
#1 Black Phoenix Black Phoenix +828.29%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.46%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.33%
#4 PondCoin PondCoin +20.90%
#5 SAFEcoin SAFEcoin +20.52%
#6 Magma Finance Magma Finance +19.50%
#7 Bless Bless +19.26%
#8 Beam Beam +18.96%
#9 pipedog pipedog +17.58%
#10 YFSX YFSX +16.02%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Rang in Aktien #6296
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Aktienkurs
$115.48
Marktkapitalisierung
$2.12B
Veränderung (1 Tag)
0.72%
Veränderung (1 Jahr)
29.38%
Land
KR
Handel Voronoi, Inc. (310210)

Kategorie

Healthcare
EPS für Voronoi, Inc. (310210)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Voronoi, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Voronoi, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH